Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia January 31, 2025 Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia
The unexpected production of the Forssman antigen in cancer cells opens new anticancer perspectives September 01, 2023 The unexpected production of the Forssman antigen in cancer cells opens new anticancer perspectives
A proteogenomic approach offers the deepest and broadest view of what happens into a cancer cell August 14, 2023 A proteogenomic approach offers the deepest and broadest view of what happens into a cancer cell
IMMERGE: A New Generation of Experts in Immunodeficiencies in Europe will be trained at the Josep Carreras Institute July 17, 2023 IMMERGE: A New Generation of Experts in Immunodeficiencies in Europe will be trained at the Josep Carreras Institute
Researchers of the Josep Carreras Institute participate in the IV Catalan Conference on Hematology in Paraguay July 14, 2023 Researchers of the Josep Carreras Institute participate in the IV Catalan Conference on Hematology in Paraguay
Immune memory is achieved by epigenetic and topological rearrangements of DNA in immune cells July 11, 2023 Immune memory is achieved by epigenetic and topological rearrangements of DNA in immune cells
A project on circulating tumor cells, led by Dr. Manel Esteller, receives the support of the Mutua Madrileña Foundation July 07, 2023 A project on circulating tumor cells, led by Dr. Manel Esteller, receives the support of the Mutua Madrileña Foundation
Dr. Manel Esteller, awarded with the Jané Mateu Foundation Award July 03, 2023 Dr. Manel Esteller, awarded with the Jané Mateu Foundation Award
A project of Dr. Belver to attack the creation of autoantibodies in Lupus receives the support of the FEDER Foundation June 30, 2023 A project of Dr. Belver to attack the creation of autoantibodies in Lupus receives the support of the FEDER Foundation
OneChain Immunotherapeutics, spin-off of the Josep Carreras Institute, secures a pre-series A funding round June 23, 2023 OneChain Immunotherapeutics, spin-off of the Josep Carreras Institute, secures a pre-series A funding round
Dr. Marcus Buschbeck is appointed as member of the European Hematology Association’s Research Committee June 20, 2023 Dr. Marcus Buschbeck is appointed as member of the European Hematology Association’s Research Committee
